Obesity-induced adipose tissue inflammation may be a driver of cancer risk, and certain adipokines (e.g., CCL2, VEGF, IL-6, and IL-8) act as chemotherapy inducers that enhance tumor cell migration and support metastasis. This evidence concerns the gene IL6 and neoplasm.